Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01531998
Brief Title: Lenalidomide/Bortezomib/Dexamethasone & CNTO 328 in Transplant Eligible Newly Diagnosed Multiple Myeloma (MM)

First Submitted : February 9, 2012
First Submitted that Met QC Criteria : February 9, 2012
First Posted : February 13, 2012 (Estimate)

Results First Submitted : June 2, 2015
Results First Submitted that Met QC Criteria : June 2, 2015
Results First Posted : June 19, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : June 2, 2015
Last Update Posted : June 19, 2015 (Estimate)